screen_shot_2012-07-04_at_10

New head at the European Medicines Agency

pharmafile | July 4, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Merck Serono, Stallergenes 

Merck Serono’s Enrica Alteri has been appointed by The European Medicines Agency as its new head of Safety and Efficacy of Medicines in the Human Medicines Development and Evaluation Unit.

Dr Alteri brings a wealth of managerial experience to the EMA and her career to date has focused on the safety of medicines in the pharma industry, most recently as head of Risk Management and Epidemiology at Merck Serono in Geneva.

Alteri takes over from Xavier Luria, who held the position until March this year and Francesco Pignatti, the Agency’s head of Oncology, who has also been acting head of Safety and Efficacy of Medicines since March.

Advertisement

Alteri is required to declare her interests in the pharmaceutical industry and to have divested herself of any shares in pharma companies before starting work at the Agency. For Dr Alteri, all involvement in medicines from Merck Serono and Stallergenes will be transferred to her back-up manager.

Related Content

Rethinking oncology trial endpoints with generalised pairwise comparisons

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera

Santhera Pharmaceuticals has received positive final guidance from the National Institute for Care and Excellence …

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European …

The Gateway to Local Adoption Series

Latest content